OBIO — Orchestra BioMed Holdings, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1814114 ·
Last close
$5.44
Market Cap
$326.97M
52W High
$5.78
52W Low
$3.56
ADV30
269,650
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 110,000 | 78,000 | -22,076,000 | -20,691,000 | 100,658,000 | 28,367,000 | 59,466,000 |
| Dec 2025 | 30,917,000 | 30,866,000 | 6,754,000 | 6,245,000 | 114,857,000 | 34,690,000 | 61,287,000 |
| Sep 2025 | 861,000 | 812,000 | -20,313,000 | -20,828,000 | 104,807,000 | 42,012,000 | 61,068,000 |
| Jun 2025 | 836,000 | 790,000 | -19,327,000 | -19,363,000 | 42,825,000 | 18,749,000 | 42,530,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-54,515,000
Investing CF
$-29,622,000
Financing CF
$94,156,000
CapEx
$-561,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.72
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-383,270,000
Inventory
$277,000
Receivables
$84,000
ST Investments
$66,033,000
EBIT TTM
$-54,708,000
Pretax Income TTM
$-54,637,000
Interest Exp TTM
—
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$31,976,000
EBITDA
$-57,642,000
Free Cash Flow
$-31,812,624
Enterprise Value
$297,865,472
Total Cash
$109,963,000
Total Debt
$70,760,000
Shares Out
60,105,049
Trailing EPS
$-0.84
Book Value
$0.32
ROE
-397.3%
ROA
-45.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 33,482,000 | -51,807,000 | -52,701,000 | 114,857,000 | 61,287,000 | — | -48,963,000 |
| Dec 2024 | 2,638,000 | -64,301,000 | -61,024,000 | 76,173,000 | 43,215,000 | — | -50,558,000 |
| Dec 2023 | 2,760,000 | -51,506,000 | -49,120,000 | 95,212,000 | 27,169,000 | — | -46,127,000 |
| Dec 2022 | 3,533,000 | -32,657,000 | -33,608,000 | 95,572,000 | 43,038,000 | — | -29,289,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.52
Max Pain — expiry 2026-11-20
max pain strike: $5.00 · spot: $5.41 · call oi: 1,050 · put oi: 273
Expected Move to 2026-11-20:
±$2.55
(47.13%) —
implied range
$2.86 –
$7.96
· ATM straddle on $5.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ELMD | Electromed, Inc. | $333.60M | $40.29 | — |
| SMTI | Sanara MedTech Inc. | $315.88M | $34.38 | — |
| TLSI | TriSalus Life Sciences, Inc. | $314.65M | $5.11 | — |
| RCEL | AVITA Medical, Inc. | $306.49M | $9.91 | — |
| MOBI | Mobia Medical, Inc. | $365.07M | $10.98 | — |
News headlines (Yahoo Finance, 1h cache)
Orchestra BioMed to Participate in the Wells Fargo 21st Annual Healthcare Conference
2026-08-20 12:30 · Yahoo
Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates
2026-08-10 20:12 · Yahoo
Orchestra BioMed Joins Russell 3000® and Russell 2000® Indexes
2026-06-29 12:00 · Yahoo
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-06-02 20:05 · Yahoo
Favourable Signals For Orchestra BioMed Holdings: Numerous Insiders Acquired Stock
2026-05-21 11:10 · Yahoo
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Lags Revenue Estimates
2026-05-12 21:40 · Yahoo
Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates
2026-05-12 20:18 · Yahoo
Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027
2026-05-12 12:30 · Yahoo
Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement
2026-05-06 12:01 · Yahoo
FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy
2026-04-30 13:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.